Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) - Total Assets

Latest as of September 2025: TL2.15 Billion TRY ≈ $48.07 Million USD

Based on the latest financial reports, Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN) holds total assets worth TL2.15 Billion TRY (≈ $48.07 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Anatolia Tani ve Biyoteknoloji Urunleri net assets for net asset value and shareholders' equity analysis.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret - Total Assets Trend (2018–2024)

This chart illustrates how Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's total assets have evolved over time, based on quarterly financial data.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret - Asset Composition Analysis

Current Asset Composition (December 2024)

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's total assets of TL2.15 Billion consist of 42.4% current assets and 57.6% non-current assets.

Asset Category	Amount (TRY)	% of Total Assets
Cash & Equivalents	TL0.00	11.5%
Accounts Receivable	TL107.38 Million	6.0%
Inventory	TL360.98 Million	20.2%
Property, Plant & Equipment	TL0.00	0.0%
Intangible Assets	TL380.41 Million	21.3%
Goodwill	TL0.00	0.0%

Asset Composition Trend (2018–2024)

This chart illustrates how Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Anatolia Tani ve Biyoteknoloji Urunleri .

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's current assets represent 42.4% of total assets in 2024, a decrease from 50.9% in 2018.
Cash Position: Cash and equivalents constituted 11.5% of total assets in 2024, up from 4.7% in 2018.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, a decrease from 23.0% in 2018.
Asset Diversification: The largest asset category is intangible assets at 21.3% of total assets.

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Competitors by Total Assets

Key competitors of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret based on total assets are shown below.

Company	Country	Total Assets
Jafron Biomedical Co Ltd SHE:300529	China	CN¥5.54 Billion
Sinocare Inc SHE:300298	China	CN¥6.25 Billion
Shanghai Kinetic Medical Co SHE:300326	China	CN¥3.38 Billion
Eurobio Scientific SA PA:ALERS	France	€259.11 Million
EBR Systems Inc AU:EBR	Australia	AU$97.29 Million
PULSION Medical Systems SE MU:PUS	Germany	€35.15 Million
Aroa Biosurgery Ltd AU:ARX	Australia	AU$95.27 Million
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	China	CN¥805.10 Million

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.71	10.33	25.28
Quick Ratio	2.09	6.08	22.97
Cash Ratio	0.00	0.00	0.00
Working Capital	TL521.60 Million	TL682.02 Million	TL680.03 Million

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret - Advanced Valuation Insights

This section examines the relationship between Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.52
Latest Market Cap to Assets Ratio	0.03
Asset Growth Rate (YoY)	-8.5%
Total Assets	TL1.79 Billion
Market Capitalization	$55.98 Million USD

Valuation Analysis

Below Book Valuation: The market values Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret's assets decreased by 8.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (2018–2024)

The table below shows the annual total assets of Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret from 2018 to 2024.

Year	Total Assets	Change
2024-12-31	TL1.79 Billion ≈ $40.02 Million	-8.54%
2023-12-31	TL1.95 Billion ≈ $43.76 Million	+127.99%
2022-12-31	TL856.92 Million ≈ $19.19 Million	-0.33%
2021-12-31	TL859.77 Million ≈ $19.26 Million	+117.25%
2020-12-31	TL395.76 Million ≈ $8.86 Million	+1057.63%
2019-12-31	TL34.19 Million ≈ $765.70K	+72.88%
2018-12-31	TL19.77 Million ≈ $442.91K	--

About Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret

IS:ANGEN Turkey Medical Devices

Market Cap

$55.98 Million

TL2.50 Billion TRY

Market Cap Rank

#21471 Global

#365 in Turkey

Share Price

TL11.36

Change (1 day)

+1.61%

52-Week Range

TL9.75 - TL13.84

All Time High

TL23.13